Global Point of Care

m-PIMA™ Analyser

Molecular Test Results in Less Than 70 Minutes, Not Months

Fully automated nucleic acid testing platform combines the accuracy of molecular testing with a short turnaround time, allowing same day treatment decisions and consultations with patients. The portable m-PIMA™ Analyser brings HIV early infant diagnosis and HIV viral load testing to a wide range of decentralized settings, bypassing delays and inefficiencies associated with centralized testing.

The m-PIMA™ HIV-1/2 VL test is now commercially available and has received CE-IVD marking and WHO prequalification. This product is not available in the United States.